Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Neoleukin Therapeutics, Inc. NLTX

Set alert

Price alert · NLTX

All alert types
3.49 0.00 0.00%

At close · Dec 18

3.42 Day range 3.59

52-week range unavailable

Open
3.45
Prev close
3.49
Mkt cap
8.20M
Vol
109.09K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
3.42
High
3.59
Forward P/E
-20.53
Beta
1.10
Short ratio
1.70
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Nov 14, 2023
50-d avg
13.83
200-d avg
14.98
1y target
1.50

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for NLTX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1.97 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 0.0×
FY 2015: -7.2×FY 2016: -8.4×FY 2017: -5.5×FY 2018: -1.6×FY 2019: -4.8×FY 2020: -22.0×FY 2021: -4.5×FY 2022: -0.5×FY 2024: -0.9×FY 2025: 0.0×
FY 2015 5y median -0.9× FY 2025
P/S 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 2.0×FY 2019: 0.0×FY 2020: 1620×FY 2021: 44215×FY 2022: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
P/B 0.0×
FY 2015: 1.5×FY 2016: 2.2×FY 2017: 2.8×FY 2018: 0.7×FY 2019: 2.4×FY 2020: 3.8×FY 2021: 1.9×FY 2022: 0.3×FY 2024: 0.2×FY 2025: 0.0×
FY 2015 5y median 0.3× FY 2025
P/FCF 0.0×
FY 2015: -7.8×FY 2016: -10.1×FY 2017: -6.1×FY 2018: -1.6×FY 2019: -20.5×FY 2020: -27.3×FY 2021: -5.2×FY 2022: -0.6×FY 2024: -0.9×FY 2025: 0.0×
FY 2015 5y median -0.9× FY 2025
EV/EBITDA -30.4×
FY 2015: -5.5×FY 2016: -7.5×FY 2017: -4.5×FY 2018: 0.8×FY 2019: -2.8×FY 2020: -17.2×FY 2021: -2.2×FY 2022: -0.0×FY 2024: -17.8×FY 2025: -30.4×
FY 2015 5y median -17.2× FY 2025
EV/Sales 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: -1.0×FY 2019: 0.0×FY 2020: 1220×FY 2021: 22635×FY 2022: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
FCF Yield 0.0%
FY 2015: -12.9%FY 2016: -9.9%FY 2017: -16.4%FY 2018: -62.2%FY 2019: -4.9%FY 2020: -3.7%FY 2021: -19.2%FY 2022: -165.9%FY 2024: -107.8%FY 2025: 0.0%
FY 2015 5y median -19.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -130.5%FY 2019: 0.0%FY 2020: -7478.5%FY 2021: -1011633.3%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -126.3%FY 2019: 0.0%FY 2020: -7378.5%FY 2021: -1011533.3%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
ROE -34.1%
FY 2015: -20.2%FY 2016: -25.6%FY 2017: -50.7%FY 2018: -43.5%FY 2019: -49.0%FY 2020: -17.4%FY 2021: -42.5%FY 2022: -61.0%FY 2024: -24.2%FY 2025: -34.1%
FY 2015 5y median -34.1% FY 2025
ROIC -37.5%
FY 2015: -19.7%FY 2016: -26.0%FY 2017: -51.4%FY 2018: -44.7%FY 2019: -49.7%FY 2020: -12.4%FY 2021: -37.5%FY 2022: -54.1%FY 2024: -25.5%FY 2025: -37.5%
FY 2015 5y median -37.5% FY 2025
ROA -31.3%
FY 2015: -19.3%FY 2016: -24.0%FY 2017: -45.5%FY 2018: -40.7%FY 2019: -47.2%FY 2020: -15.8%FY 2021: -37.2%FY 2022: -49.6%FY 2024: -22.4%FY 2025: -31.3%
FY 2015 5y median -31.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -100.0%FY 2020: 0.0%FY 2021: -98.7%FY 2022: -100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 FY 2025
Operating Income -25.1%
FY 2015: 9.4%FY 2016: -76.4%FY 2017: -35.8%FY 2018: 36.2%FY 2019: -117.5%FY 2020: 52.5%FY 2021: -80.0%FY 2022: 2.6%FY 2024: 0.0%FY 2025: -25.1%
FY 2015 FY 2025
EPS (diluted) 100.0%
FY 2015: 37.0%FY 2016: -13.2%FY 2017: -9.3%FY 2018: 87.5%FY 2019: -859.0%FY 2020: 75.1%FY 2021: -71.9%FY 2022: 7.8%FY 2024: 0.0%FY 2025: 100.0%
FY 2015 FY 2025
Free Cash Flow -9.7%
FY 2015: -13.3%FY 2016: -52.4%FY 2017: -46.1%FY 2018: 30.0%FY 2019: 48.5%FY 2020: -64.7%FY 2021: -89.7%FY 2022: 8.1%FY 2024: 0.0%FY 2025: -9.7%
FY 2015 FY 2025

Financial Health

Current Ratio 16.6×
FY 2015: 15.6×FY 2016: 10.9×FY 2017: 9.9×FY 2018: 16.7×FY 2019: 30.3×FY 2020: 24.7×FY 2021: 16.7×FY 2022: 9.0×FY 2024: 20.8×FY 2025: 16.6×
FY 2015 5y median 16.7× FY 2025
Quick Ratio 16.6×
FY 2015: 15.6×FY 2016: 10.9×FY 2017: 9.9×FY 2018: 16.7×FY 2019: 30.3×FY 2020: 24.7×FY 2021: 16.7×FY 2022: 9.0×FY 2024: 20.8×FY 2025: 16.6×
FY 2015 5y median 16.7× FY 2025
Debt / Equity 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.1× FY 2025
Net Debt / EBITDA -30.4×
FY 2015: 1.8×FY 2016: 0.9×FY 2017: 1.0×FY 2018: 2.4×FY 2019: 2.1×FY 2020: 5.7×FY 2021: 2.1×FY 2022: 0.5×FY 2024: -38.2×FY 2025: -30.4×
FY 2015 5y median 0.5× FY 2025
Interest Coverage 20666×
FY 2015: -216×FY 2016: -37645×FY 2017: -12780×FY 2018: -8156×FY 2019: -70959×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -37.4×FY 2024: 6884×FY 2025: 20666×
FY 2015 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31